National Bank of Canada’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75M | Buy |
142,812
+44,828
| +46% | +$23.5M | 0.07% | 197 |
|
|
2025
Q1 | $62.1M | Sell |
97,984
-5,667
| -5% | -$3.59M | 0.07% | 223 |
|
|
2024
Q4 | $73.8M | Buy |
103,651
+32,492
| +46% | +$23.1M | 0.08% | 197 |
|
|
2024
Q3 | $74.8M | Buy |
71,159
+28,365
| +66% | +$29.8M | 0.09% | 189 |
|
|
2024
Q2 | $45.2M | Sell |
42,794
-2,347
| -5% | -$2.48M | 0.06% | 211 |
|
|
2024
Q1 | $44M | Sell |
45,141
-71,086
| -61% | -$69.2M | 0.07% | 202 |
|
|
2023
Q4 | $105M | Buy |
116,227
+71,838
| +162% | +$65M | 0.17% | 114 |
|
|
2023
Q3 | $36.3M | Buy |
44,389
+6,315
| +17% | +$5.17M | 0.06% | 228 |
|
|
2023
Q2 | $27.3M | Buy |
38,074
+22,875
| +151% | +$16.4M | 0.05% | 250 |
|
|
2023
Q1 | $12.5M | Buy |
15,199
+773
| +5% | +$635K | 0.03% | 326 |
|
|
2022
Q4 | $10.4M | Buy |
14,426
+5,036
| +54% | +$3.63M | 0.03% | 381 |
|
|
2022
Q3 | $6.55M | Sell |
9,390
-1,059
| -10% | -$738K | 0.04% | 403 |
|
|
2022
Q2 | $6.19M | Buy |
10,449
+3,448
| +49% | +$2.04M | 0.03% | 414 |
|
|
2022
Q1 | $4.93M | Sell |
7,001
-1,318
| -16% | -$928K | 0.01% | 484 |
|
|
2021
Q4 | $5.23M | Buy |
+8,319
| New | +$5.23M | 0.02% | 473 |
|